Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

NCT01136252 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Age-Related Macular Degeneration
Choroidal Neovascularization

Interventions

DRUG: Adalimumab

Sponsor

Hospital Universitari Vall d'Hebron Research Institute